The Hidden Value of Onsite Monitoring

October 18, 2017 – Ellie Einolhayat, RN, a Lexitas monitor (clinical research associate) provides insight on the role onsite monitors have in identifying issues with protocol design and other challenges that come with successfully executing a clinical trial.  To learn about this and more, please read the attached article published in the August 2017 edition of Clinical Researcher.

Additional Resources

Lexitas Announces Acquisition of Erie Retina Research

Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie

Read More
Lexitas and NAMSA announce strategic partnership for ophthalmic medical device development

Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

Read More
Cell & Gene Therapy in Ophthalmology

Webinar: Cell & Gene Therapy in Ophthalmology

Read More
A Vision for Growth by Jeanne Hecht and David Tanzer, MD

A Vision for Growth

Read More
Expanding horizons: Why ophthalmology practices should consider embracing clinical trials

Expanding horizons: Why ophthalmology practices should consider embracing clinical trials

Read More
Professional headshot of Emily Simpson, VP of Marketing for Lexitas

Navigating Ophthalmology: A Strategic Guide for Biotech Companies Entering the Space

Read More